Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
J
127120
vs
K
KOSPI 200
Over the past 12 months, JS Link Inc has underperformed KOSPI 200, delivering a return of +30% compared to KOSPI 200's +106% growth.
Stocks Performance
127120 vs KOSPI 200
Performance Gap
127120 vs KOSPI 200
Performance By Year
127120 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JS Link Inc
Glance View
DNA Link is a South Korean biotechnology company focused on genetic testing and genomics services. It analyzes DNA samples for hospitals, research groups, and individuals, and it also develops tests and software that help interpret genetic data. In simple terms, it turns raw DNA information into reports that can support disease screening, research, and personal health analysis. The company makes money by selling laboratory testing services, genetic analysis products, and related research services. Its main customers are medical institutions, pharmaceutical and biotech companies, academic researchers, and some direct-to-consumer users who want ancestry or health-related DNA information. DNA Link sits in the middle of the genomics value chain: it is not a drug maker, but a specialist that generates and interprets the data others use. What makes its business model different is that it earns revenue from both routine testing and specialized analysis work. That gives it exposure to two markets at once: clinical diagnostics and life-science research. The company’s role depends on trust in its test quality, data handling, and ability to turn complex genetic information into useful results.